GNH USA

Europe — EMA

Orindille (Drospirenone, Ethinylestradiol)

Drospirenone, the active ingredient in Orindille, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and manages hormonal balance in women of reproductive age.

Request sourcing

1
Pack/s

What is Drospirenone, Ethinylestradiol?

Drospirenone, the active ingredient in Orindille, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and manages hormonal balance in women of reproductive age. GNH USA supplies Orindille as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orindille as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Drospirenone, Ethinylestradiol used for?

Orindille is a combined oral contraceptive that acts on the hormonal regulation pathway to prevent pregnancy. - Contraception: Provides reliable prevention of ovulation and pregnancy when taken as directed. - Menstrual cycle regulation: Helps stabil the menstrual cycle by reducing irregular bleeding and spotting. - Acne‑related hormonal hationale : Improves acne by modulating and hunting … -  ... ... ...   t  ??  .... … … ... ... 

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Drospirenone, Ethinylestradiol
Route
Oral Use
Manufacturer
Orivas
Origin
EU

Related products